Detalhe da pesquisa
1.
The impact of COVID-19 vaccine reactions on secondary vaccine hesitancy.
Ann Allergy Asthma Immunol
; 132(5): 630-636.e1, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232816
2.
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis
; 76(3): e526-e529, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737946
3.
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring.
J Am Acad Dermatol
; 88(5): 1066-1073, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641010
4.
The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections.
J Am Acad Dermatol
; 87(6): 1278-1280, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075281
5.
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
N Engl J Med
; 387(3): 275-277, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767428
6.
HIV and mpox: Evaluation of clinical course and outcomes from an international dermatologic registry.
J Am Acad Dermatol
; 90(5): 1011-1013, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157988
7.
Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
AIDS
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507584
8.
Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure.
AIDS
; 37(7): 1109-1113, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928169
9.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
JCI Insight
; 7(19)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214224
10.
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
medRxiv
; 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262089
11.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
medRxiv
; 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262094
12.
Data Resource Profile: The Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC).
Int J Epidemiol
; 51(6): e337-e349, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762972